N-MOmentum Archives - Medical Conferences

Eculizumab, satralizumab, or inebilizumab for NMOSD?

Presented By

Prof. Dean Wingerchuk, Mayo Clinic Phoenix/Scottsdale, AZ, USA

Trial

Phase 3, N-MOmentum, PREVENT, SAkuraStar, SAkuraSky

Conference

ECTRIMS 2021

Type

Peer-reviewed article

9 December 2021 15:37

Long-term efficacy data: inebilizumab for NMOSD

Presented By

Prof. Bruce Cree, UCSF Multiple Sclerosis Center, CA, USA

Trial

Phase 3, N-MOmentum

Conference

ECTRIMS 2021

Type

Peer-reviewed article

9 December 2021 15:31

Good long-term safety and efficacy of inebilizumab in NMOSD

Presented By

Prof. Bruce Cree, University of California San Francisco, CA, USA

Trial

Phase 3, N-MOmentum

Conference

EAN 2021

Type

Peer-reviewed article

18 August 2021 10:28

Targeted therapies for NMOSD in development

Presented By

Dr Dean Wingerchuk, Mayo Clinic, Rochester, United States

Trial

Phase 3, PREVENT

Conference

ECTRIMS 2019

Type

Peer-reviewed article

8 November 2019 11:17

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com